AI and early digital twin models can help forecast trial performance, refine site feasibility, and anticipate operational needs before enrollment begins.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
ON-DEMAND WEBINARS
TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration technology, and setting up successful eCOA solutions.
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.
See how digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial were endorsed by the FDA, marking an important milestone.
Explore how the new ICH E6 (R3) revisions are reshaping clinical trial oversight and examine how AI-driven tools like the Clinical Decision Suite can help sponsors enhance trial efficiency.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1391107099 nurse patient]( "4 Ways Home Visits Support Successful Rare Disease Clinical Trials")
4 Ways Home Visits Support Successful Rare Disease Clinical TrialsResearchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
![GettyImages-1403839079-computer-tablet-laptop-data-research]( "Navigating The Complexities Of Publication Planning")
Navigating The Complexities Of Publication PlanningIn the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.
-
![GettyImages-2181934436-laboratory-analysis-scientists-technology-computer]( "Virtual eConsent For Decentralized Trials")
Virtual eConsent For Decentralized TrialsVirtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
![GettyImages-1646106148-AI-pharma-healthcare]( "AI In Clinical Trials: Key Insights From Industry Experts")
AI In Clinical Trials: Key Insights From Industry ExpertsFind out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.
-
![GettyImages-1305685152 vaccine]( "eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks")
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 WeeksExamine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
![Efficiency Guest Column_Getty-1347568261]( "Navigating The Next Wave Of Innovation In eCOA")
Navigating The Next Wave Of Innovation In eCOALearn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.
-
![Thinking Pragmatically About The Future Of Real World Evidence]( "Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development")
Single-Arm Trials Use Real-World Evidence For Rare Disease Drug DevelopmentIn rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.
-
![GettyImages-1127397327-team-planning-meeting-boardroom-partnership]( "How Data Collection Is Enabling CROs To Expand Service Offerings")
How Data Collection Is Enabling CROs To Expand Service OfferingsExplore how innovative processes and advanced data collection technologies like ePRO and eCOA can help contract research organizations expand their service offerings.
-
![epro-GettyImages-2225338995]( "What Is ePRO?")
What Is ePRO?Real-time patient reporting improves data quality and trial insight. Digital tools cut missing data, enable remote participation, and clarify how treatments affect daily life.
-
![sitees-GettyImages-1058161052]( "The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation")
The Site-Sponsor Digital Divide Is Slowing Clinical Trial InnovationClinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
